BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Tata Chemicals Ltd.’s Q4 FY21 revenues grew 11% YoY to Rs 2,636 crore, mainly due to 38% YoY growth (albeit on lower base) in speciality product segment to Rs 519.6 crore.
Basic chemical revenues grew 6% YoY to Rs 2,111.3 crore mainly led by 12% growth in India, while the U.S. and Europe grew 1% and 5%, respectively.
Ebitda margins declined 610 basis points to 10.7% mainly due to one-offs, negative operational leverage and spillover of cost to Q4 from Q3 in U.S. and Europe.
Ensuing Ebitda declined 29% YoY to Rs 282.7 crore.
Profit after tax declined 94% YoY to Rs 11.8 crore amid lower operational performance and higher tax rate.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.